PharmGKB Blog
Thursday, March 25, 2021

PharmGKB introduces scoring system for variant and clinical annotations and updated Levels of Evidence

›
Since their introduction in 2010, clinical annotations have become one of the most popular features of PharmGKB. Each clinical annotation s...
Tuesday, March 23, 2021

Two new pathways released: Allopurinol Pharmacokinetics and Pimozide Pharmacokinetics.

›
Allopurinol is a purine analogue used in the treatment of gout. This drug has a level A CPIC Guideline for allopurinol and HLA-B . The new p...
Monday, March 1, 2021

Milestones in Payer Coverage Set to Expand Pharmacogenomic Testing

›
  A new perspective just out in   Genetics in Medicine   describes the improvements in the US payer landscape for pharmacogenomics test reim...
Friday, February 19, 2021

PharmGKB and CPIC curated information displayed on ClinGen

›
PharmGKB and CPIC partnered with ClinGen last summer  to bring curated pharmacogenomics (PGx) to the resource which defines the clinical ...
Thursday, February 18, 2021

Plavix manufacturers to pay $834 million to state of Hawaii

›
Bristol-Myers Squibb Co and Sanofi, the manufacturers of Plavix (clopidogrel) have been ordered to pay over $834 million to the state of Haw...
Tuesday, February 16, 2021

HGVS annotations now available on PharmVar

›
We are excited to share that PharmVar is now providing HGVS annotations in addition to their more traditional annotations. To accommodate d...
Wednesday, February 10, 2021

Update to FDA-approved drug label annotations

›
In February 2020, we blogged about the FDA's newly released Table of Pharmacogenetic Associations . Since then, there has been much int...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.